Pharyngeal packs during surgery

Phase 2

• Conditions: Deviated nasal septum; septorhynoplasty.

• Registration Number: IRCT2013011012094N1
• Lead Sponsor: Vice Chancellor for Research, Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Inclusion criteria: after regional ethical committee approval and written informed consent to participate in the study, all ASAI-II patients candid septorhinoplasty.
Exclusion criteria: history of motion sickness; common cold with sore throat; consumption of analgesics in the past 48 hours; a history of substance abuse and smoking; difficult intubation and repeat laryngoscopy

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ausea & Vomiting. Timepoint: Post operative times:0 (recovery), 2 , 6 and 24 h. Method of measurement: Nausea: No or Yes (mild or severe), vomiting: Yes or No.;Sore throat. Timepoint: Post operative times:0 (recovery), 2 , 6 and 24 h. Method of measurement: Visual analog scale(VAS): Pain from 0=no pain to 10=sever pain.

Secondary Outcome Measures

Name	Time	Method
Duration of surgery. Timepoint: Beginning of anesthesia until extubation. Method of measurement: Hour.;Concomitant disease. Timepoint: Questionnaire preoperatively. Method of measurement: Patient history.;Receiving narcotic. Timepoint: Postoperative time. Method of measurement: The number of narcotic injection. Recorded in the questionnaire.